Blog Posts - Sofosbuvir/cost



Wider access to hepatitis C drugs is humane and pragmatic

Wider access to hepatitis C drugs is humane and pragmatic  Boston Globe The long-term health prospects for thousands of Massachusetts residents are about to improve. As of Monday, MassHealth... Monday HCV News Ticker- Hepatitis C: Coffee, Med...
by HCV New Drug Research on Jul 29, 2016

UK health service under fire over access to hepatitis C drugs

Feature Investigation A pill too hard to swallow: how the NHS is limiting access to high priced drugs (Published 27 July 2016) Cite this as: BMJ 2016;354:i4117 A joint investigation by The BMJ and... Monday HCV News Ticker- Hepatitis C: Coffee, Med...
by HCV New Drug Research on Jul 28, 2016

New Poll - 64 Percent of Global Doctors Believe New Hepatitis C Drugs Are Worth the Cost

New Poll Finds 64 Percent of Global Doctors Believe New Hepatitis C Drugs Are Worth the Cost July 21, 2016 01:46 PM Eastern Daylight Time NEW YORK--(BUSINESS WIRE)--In advance of World... Monday HCV News Ticker- Hepatitis C: Coffee, Medica...
by HCV New Drug Research on Jul 21, 2016

Listen: Hep C Buyers Club

Radio New Zealand From Jesse Mulligan, 1–4pm This story was broadcast on Monday 11 July 2016 Hep C Buyers Club 1:27 pm on 11 July 2016 Hazel Heal has suffered from Hepatitis C for about 30 years,... Monday HCV News Ticker- Hepatitis C: Coffee, M...
by HCV New Drug Research on Jul 11, 2016

Listen: Hep C Buyers Club

Radio New Zealand From Jesse Mulligan, 1–4pm This story was broadcast on Monday 11 July 2016 Hep C Buyers Club 1:27 pm on 11 July 2016 Hazel Heal has suffered from Hepatitis C for about 30 years,... Monday HCV News Ticker- Hepatitis C: Coffee, M...
by HCV New Drug Research on Jul 11, 2016

Watch - New Opportunities and Challenges in Hepatitis C

New Opportunities and Challenges in Hepatitis C The American Journal of Managed Care Hepatitis C is an enormously common disease that is often initially asymptomatic. New drugs are very effective,... Monday HCV News Ticker- Hepatitis C: Coffee, Med...
by HCV New Drug Research on Jul 11, 2016

Help with the high cost of hepatitis C drugs

Help with the high cost of hepatitis C drugs Judith Graham, Kaiser Health News After legal battles and lobbying efforts, thousands of people with hepatitis C are gaining earlier access to expensive... Monday HCV News Ticker- Hepatitis C: Coffee, Me...
by HCV New Drug Research on Jul 2, 2016

Kiwis chase overseas drugs to help battle Hepatitis C

Kiwis chase overseas drugs to help battle Hepatitis C CATE BROUGHTON Last updated 05:00, June 18 2016 50,000 people have Hep C in New Zealand, but a recent Pharmac announcement about funding for... Monday HCV News Ticker- Hepatitis C: Coffee, Med...
by HCV New Drug Research on Jun 17, 2016

Making Hepatitis C A Rare Disease In The United States

Making Hepatitis C A Rare Disease In The United States Victor Roy, Dave Chokshi, Stephen Kissler, and Prabhjot Singh New breakthrough medicines for Hepatitis C present an important choice about... Monday HCV News Ticker- Hepatitis C: Coffee, Medicar...
by HCV New Drug Research on Jun 15, 2016

Hep C sufferers angered by activist website ban - fixhepc website will be geoblocked

A website which raises awareness about a medical cure for hepatitis C could be hidden from Australians. 11:09pm, Jun 14, 2016 Richard Woolveridge Hepatitis C patients are angry and perplexed that... Monday HCV News Ticker- Hepatitis C: Coffee, Med...
by HCV New Drug Research on Jun 14, 2016

Ireland: HSE to expand hepatitis C treatment programme

HSE to expand hepatitis C treatment programme Paul Cullen, Sorcha Pollak An estimated 20,000 to 50,000 people in Ireland chronically infected with the disease Anti-viral drugs that can cure... Monday HCV News Ticker- Hepatitis C: Coffee, Medicare,...
by HCV New Drug Research on Jun 14, 2016

Drug Rationing Plays Russian Roulette With Patients’ Lives

Drug Rationing Plays Russian Roulette With Patients’ Lives Stacey Worthy | June 10, 2016 This game of Russian roulette is played every day.  Consumers can find their health at risk because... Monday HCV News Ticker- Hepatitis C: Coffee,...
by HCV New Drug Research on Jun 10, 2016

Washington state told to lift restrictions on hepatitis C medicines

Washington state told to lift restrictions on hepatitis C medicines By Ed Silverman @PharmalotMay 27, 2016 The Washington state Medicaid program has been ordered to lift restrictions on... Monday HCV News Ticker- Hepatitis C: Coffee, Medicare,...
by HCV New Drug Research on May 28, 2016

Big Pharma: Pushing the Edge of the Envelope

Big Pharma: Pushing the Edge of the Envelope by Caroline Poplin MD, JD Wall Street's drive for profits is hiking drug prices, says Caroline Poplin, MD, JD The good news: in the last 20 years,... Monday HCV News Ticker- Hepatitis C: Coffee, Medicar...
by HCV New Drug Research on May 24, 2016

"Pay For Performance" Drug Plans Could Impact Biopharma's R&D Priorities

"Pay For Performance" Drug Plans Could Impact Biopharma's R&D Priorities John LaMattina , Contributor As healthcare costs continue to rise, payers are seeking ways to get prices under control.... Monday HCV News Ticker- Hepatitis C: Coffee, Me...
by HCV New Drug Research on May 18, 2016

Gilead Sciences' patent on hepatitis C drug sofosbuvir challenged in Delhi High Court Our Bureau, Mumbai

Gilead Sciences' patent on hepatitis C drug sofosbuvir challenged in Delhi High Court Our Bureau, Mumbai Tuesday, May 17, 2016, 08:00 Hrs [IST] The US-based Initiative for Medicines, Access &... Monday HCV News Ticker- Hepatitis C: Coffee, Me...
by HCV New Drug Research on May 17, 2016

The curious case of generic Hep C drug sofosbuvir

The curious case of generic Hep C drug sofosbuvir LEENA MENGHANEY Flip-flop around its patent in India points to need for developing nations to band for tech For more than a decade, an academic... Monday HCV News Ticker- Hepatitis C: Coffee, Med...
by HCV New Drug Research on May 16, 2016

The cost of drugs is killing us. How can we foster access for all?

The cost of drugs is killing us. How can we foster access for all? Over the past year, high medicine prices have made the headlines. In the UK, two cancer treatments were dropped because they were... Monday HCV News Ticker- Hepatitis C: Coffee, Me...
by HCV New Drug Research on May 15, 2016

Vermont to Require Drug Makers to Explain Price Increases

Vermont to Require Drug Makers to Explain Price Increases By dave gram, associated pressMONTPELIER, Vt. — May 14, 2016, 8:54 AM ET Vermont is poised to become the first state requiring drug... Monday HCV News Ticker- Hepatitis C: Coffee, Medicare...
by HCV New Drug Research on May 14, 2016

It’s Time to End Insurance Restrictions on Life-Saving Hepatitis C Treatments

May Special Issue: HCV The American Journal of Managed Care - 2016 The American Journal of Managed Care is the leading peer-reviewed journal dedicated to issues in managed care. AJMC.com distributes... Monday HCV News Ticker- Hepatitis C: Coffee, M...
by HCV New Drug Research on May 4, 2016


Trending Topics

Close